skyrizi

Generic: risankizumab-rzaa

Labeler: abbvie inc.
NDC Directory HUMAN PRESCRIPTION DRUG BLA Inactive Finished

Drug Facts

Product Profile

Brand Name skyrizi
Generic Name risankizumab-rzaa
Labeler abbvie inc.
Dosage Form INJECTION
Routes
SUBCUTANEOUS
Active Ingredients

risankizumab 150 mg/mL

Manufacturer
AbbVie Inc.

Identifiers & Regulatory

Product NDC 0074-2100
Product ID 0074-2100_247cc009-6d45-4bff-a04d-8e166830d677
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category BLA
Application Number BLA761105
Listing Expiration 2026-12-31
Marketing Start 2021-04-26

Pharmacologic Class

Established (EPC)
interleukin-23 antagonist [epc]
Mechanism of Action
interleukin-23 antagonists [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 00742100
Hyphenated Format 0074-2100

Supplemental Identifiers

RxCUI
797544 2166136 2166137 2166142 2166143 2540692 2540695 2540698 2540699 2604618 2604622 2604625 2604628 2613758 2613759 2632994 2632997 2632999 2633000 2633001 2633002 2723331 2723332
UNII
90ZX3Q3FR7
NUI
N0000192799 N0000192798

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name skyrizi (source: ndc)
Generic Name risankizumab-rzaa (source: ndc)
Application Number BLA761105 (source: ndc)
Routes
SUBCUTANEOUS
source: ndc

Resolved Composition

Strengths
  • 150 mg/mL
source: ndc
Packaging
  • 1 SYRINGE in 1 CARTON (0074-2100-01) / 1 mL in 1 SYRINGE
  • 1 SYRINGE in 1 CARTON (0074-2100-70) / 1 mL in 1 SYRINGE
source: ndc

Packages (2)

0074-2100-01 1 SYRINGE in 1 CARTON (0074-2100-01) / 1 mL in 1 SYRINGE 0074-2100-70 1 SYRINGE in 1 CARTON (0074-2100-70) / 1 mL in 1 SYRINGE

Ingredients (1)

risankizumab (150 mg/mL)

Linked Drug Pages (1)

Skyrizi ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["SUBCUTANEOUS"], "spl_id": "247cc009-6d45-4bff-a04d-8e166830d677", "openfda": {"nui": ["N0000192799", "N0000192798"], "unii": ["90ZX3Q3FR7"], "rxcui": ["797544", "2166136", "2166137", "2166142", "2166143", "2540692", "2540695", "2540698", "2540699", "2604618", "2604622", "2604625", "2604628", "2613758", "2613759", "2632994", "2632997", "2632999", "2633000", "2633001", "2633002", "2723331", "2723332"], "spl_set_id": ["7148c8eb-b39e-e20a-6494-a6df82392858"], "pharm_class_epc": ["Interleukin-23 Antagonist [EPC]"], "pharm_class_moa": ["Interleukin-23 Antagonists [MoA]"], "manufacturer_name": ["AbbVie Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 SYRINGE in 1 CARTON (0074-2100-01)  / 1 mL in 1 SYRINGE", "package_ndc": "0074-2100-01", "marketing_start_date": "20210426"}, {"sample": true, "description": "1 SYRINGE in 1 CARTON (0074-2100-70)  / 1 mL in 1 SYRINGE", "package_ndc": "0074-2100-70", "marketing_start_date": "20210426"}], "brand_name": "Skyrizi", "product_id": "0074-2100_247cc009-6d45-4bff-a04d-8e166830d677", "dosage_form": "INJECTION", "pharm_class": ["Interleukin-23 Antagonist [EPC]", "Interleukin-23 Antagonists [MoA]"], "product_ndc": "0074-2100", "generic_name": "risankizumab-rzaa", "labeler_name": "AbbVie Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Skyrizi", "active_ingredients": [{"name": "RISANKIZUMAB", "strength": "150 mg/mL"}], "application_number": "BLA761105", "marketing_category": "BLA", "marketing_start_date": "20210426", "listing_expiration_date": "20261231"}